Thales Unveils New Secrets Management Solution to Help Reduce Risks and Improve DevOps and Cloud Security
24.4.2023 16:00:00 EEST | Business Wire | Press release
Thales, the leading global technology and security provider, today announced the introduction of a new secrets management solution as part of its CipherTrust Data Security platform which unifies the discovery, classification, protection, and control of sensitive data across cloud, on-premises and hybrid environments. Thales’s new secrets management solution, powered by Akeyless’ Vault Platform, enables customers to manage and secure DevOps and cloud workloads’ secrets. The new capability enhances the capabilities of the CipherTrust Data Security platform to help security and governance teams reduce risks by streamlining security processes across their operations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230424005088/en/
@Thales
Thales’ new secrets management solution helps ensure that only authorized workloads and applications can access their passwords, API keys, and certificates, protecting them from unauthorized access, theft, or misuse. The process of secrets management typically involves generating and storing secrets securely, controlling access, and monitoring to alert when there is a suspicion of a breach and associated details.
Todd Moore, vice president of data security products at Thales: "Combining secrets management with key management is like having a fortified vault for all your valuable assets. We are pleased to meet our customers growing business needs by offering a single data security platform that can simplify the management of all their sensitive data, improve security and compliance, foster development collaboration, and scale their security infrastructure."
The addition of secrets management enables the CipherTrust Data Security Platform to solve several pain points for customers related to the storing and managing of secrets securely, including:
- Mitigating the risk of data breaches: By providing secure storage and access control to sensitive data such as passwords, API keys, and certificates, which are valuable targets for attackers, it mitigates the risk of data breaches.
- Simplifying the management of secrets: In many organizations, passwords and certificates are managed manually or with ad-hoc processes, which are time-consuming and error-prone, especially in large or complex environments.
- Ensuring compliance with regulations and standards: Some industries and regions require compliance with specific regulations and standards for data security which could be very complex to navigate.
- Enabling collaboration: Multiple teams or individuals who need access to secrets now have a centralized and secure way to collaborate on projects.
With support for secrets management, the CipherTrust Data Security Platform further simplifies customers' processes by allowing centralized management of secrets and keys and scaling up to encryption solutions and other data security use cases.
Shai Onn, President & Co-founder at Akeyless : “As enterprises increasingly adopt DevOps practices, Automation, containerization, and more cloud technologies, they face a new rising threat in the form of Secrets Sprawl, where credentials, certificates and keys of all forms are being found in large quantities within source code, configuration files, and DevOps automation platforms. In recent years, Akeyless has pioneered the SaaS based Secrets Management market, becoming the perfect choice for reputable enterprises globally, making it a natural partner for Thales. With Akeyless Vault Platform’s secrets management solution, Thales can offer a more holistic and cohesive platform for its customers enabling them to centralize and streamline their DevOps Security efforts, Cloud IAM initiatives and Encryption solutions projects.
For a demo, visit Thales’ booth #N-5369 and Akeyless.io’s booth #S-1861 at RSA 2023 (April 24 – 27 in San Francisco, USA) or learn more here.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum technologies – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organizations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfill their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 77,0001 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.
PLEASE VISIT
Thales Group
Cloud Protection & Licensing Solutions | Thales Group
Cybersecurity Solutions | Thales Group
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230424005088/en/
Contact information
PRESS CONTACT
Thales, Media Relations
Security & Cybersecurity
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 02:00:00 EEST | Press release
Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for people living with FOP, bringing a new treatment option to adult and pediatric patients living with this devastating disease,” said Chris Peetz, Chief Executive Officer at Mirum. “At Mirum, we are driven to serve rare disease communities where the unmet need is significant and the opportunity to make a difference is profound. The approval of Atebrioz reflects what can be achieved when industry, researchers
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 22:19:00 EEST | Press release
At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where Digital Reef will purchase verified environmental assets generated by Oreasoc, supporting the development of low-carbon data centres mitigating their environmental footprint through the protection of high-integrity natural ecosystems across the South American Amazon, whilst advancing sustainable economic development. AI and data centre demand is driving rapid growth, with the International Energy Agency project
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 16:00:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata from data and enables metadata services to scale independently, creating a foundation for AI infrastructure capable of supporting trillions of files, exabyte-scale environments, and massively pa
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 15:57:00 EEST | Press release
MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity, technology, infrastructure, execution, market access and tailored client solutions within an integrated financial ecosystem. The second award acknowledg
Croma-Pharma Introduces saypha ® volume prime Lidocaine25.9.2026 15:04:00 EEST | Press release
Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine, Croma-Pharma further strengthens its product range, reflecting the company's long-standing commitment to scientific excellence and continuous product innovation, and provid
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
